Latest News
China-focused hedge funds including Triata Capital delivered standout gains in the first half of 2025, outperforming global peers on the back of a sharp rebound in Hong Kong-listed equities and bets on AI and emerging consumption trends, according to a report by Reuters.
Multi-strategy major Millennium Management has allocated $4.2bn to two independent hedge fund managers, reinforcing its strategy of seeding top-tier external talent amid surging assets under management, according to a report by Bloomberg.
Investor redemptions from hedge funds hit a 12-month low in July, according to the latest data from SS&C Technologies, with the firm’s SS&C GlobeOp Forward Redemption Indicator falling to 1.56% for July, down from 2.27% in the previous month.
Universal Music Group has confidentially filed for a US listing, a move which would fulfil an agreement with Bill Ackman’s hedge fund firm Pershing Square, a long-time advocate for a transatlantic shift to unlock greater shareholder value, according to a report by Bloomberg.
Equity Data Science (EDS) has unveiled Fusion, a new generative AI-powered platform aimed at transforming and streamlining how institutional investors manage data and decision-making across the investment lifecycle.
Toronto-based hedge fund manager Waratah Capital Advisors, which oversees CAD4bn in assets, is investigating a cybersecurity breach that may have exposed sensitive client information, according to a report by the Globe & Mail.
Neville Shah, co-founder of shuttered hedge fund Kodai Capital Management, has joined $77bn multi-strategy powerhouse Millennium Management as a senior member of its equities management team, according to a report by Bloomberg citing an unnamed source familiar with the matter.
Los Angeles-based hedge fund Glendon Capital Management is positioning itself to capitalise on what it sees as the slow unraveling of the private equity boom, as liquidity pressures mount and sponsors struggle to exit ageing investments, according to a report by Bloomberg.
Walleye Capital has joined a growing cohort of elite multi-strategy hedge funds shutting their doors to new investor capital, as the $8bn firm seeks to maintain performance and absorb recent growth, according to a report by Bloomberg.
Activist hedge funds, including Tang Capital Management, are zeroing in on the biotech sector, targeting nearly $30bn in underutilised capital tied up in early-stage drug developers, according to a report by Bloomberg.
